BioSpace News Archive

Relay and Fio Report Successful COVID-19 Testing at Tennis Canada’s 2021 National Bank Open Presented by Rogers in Toronto

LifeLabs LP (“LifeLabs”), Canada’s leading provider of laboratory diagnostic information and health connectivity solutions, deployed the Fionet platform for testing athletes, officials, tournament employees, and other attending personnel at the tournament.

August 24, 2021
·
6 min read
Drug Development

Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis

Myocarditis is an acute inflammatory condition of the myocardium, characterized by inflammation of the heart muscle, which may result in chest pain, impaired cardiac function, atrial and ventricular arrhythmias, and conduction disturbances.

August 24, 2021
·
7 min read
Business

Dr. Craig Bunnell Joins Advisory Board of Cancer Diagnostic and Precision Oncology Platform Developer 4D Path

4D Path is pleased to announce that Dr. Craig A. Bunnell, MD, MPH, MBA, has joined the company’s distinguished advisory board.

August 24, 2021
·
4 min read
Drug Development

HCW Biologics Showcases Scientific Paper in Molecular Therapy Highlighting Potential of HCW9218 as Novel, Bifunctional Cancer Immunotherapeutic

HCW Biologics Inc. announced the publication of a scientific paper, authored by the Company’s scientific research team in the peer-reviewed journal, Molecular Therapy.

August 24, 2021
·
6 min read
Oragenics Announces Postponement of Annual Meeting of Shareholders

Oragenics, Inc. today announced the Company’s reconvened annual meeting of shareholders, on August 23, 2021 at 4:00 p.m. was adjourned due to a lack of quorum.

August 24, 2021
·
4 min read
Biotech Beach

Adamis Pharmaceuticals Announces a Publication with the Human Immune Monitoring Center at Stanford Demonstrating Tempol Significantly Inhibited Multiple Cytokines from COVID-19 Patient’s Cells

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced a publication in the peer reviewed journal, Clinical Immunology, entitled “Tempol, a novel antioxidant, inhibits both activated T cell and APC (Antigen Presenting Cell) derived cytokines in-vitro from COVID-19 patients.”

August 24, 2021
·
7 min read
Drug Development

Timber Pharmaceuticals Announces Last Patient Last Visit in Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis

Timber Pharmaceuticals, Inc. today announced that the last patient completed their last patient completed their last visit in the Phase 2b CONTROL study evaluating TMB-001

August 24, 2021
·
4 min read
Alimera Sciences Announces National Pricing and Reimbursement Granted for ILUVIEN® for DME in Belgium

Alimera Sciences, Inc. announces that Alimera Sciences Europe Limited, its Ireland-based European subsidiary, received pricing and reimbursement approval for ILUVIEN ® for diabetic macular edema (DME) in Belgium from the National Institute for Health and Disability Insurance (INAMI).

August 24, 2021
·
5 min read
Drug Development

Cartesian Therapeutics Announces Clinical Responses in First Cohort of Phase 1b/2a Trial in Myasthenia Gravis

Cartesian Therapeutics today announced clinical data from the first cohort of an ongoing Phase 1/2a clinical trial of Descartes-08 in patients with generalized Myasthenia Gravis (gMG). Descartes-08 is an mRNA-modified, autologous CAR T-cell product directed against B-Cell Maturation Antigen (BCMA).

August 24, 2021
·
4 min read
Deals

Amyris Closes Acquisitions Of OLIKA Inc. And MG Empower

Amyris, Inc. (Nasdaq: AMRS), today announced that it closed the acquisitions of OLIKA, Inc. (OLIKA), an award-winning clean consumer brand, and MG Empower Ltd., a leading global influencer marketing agency on August 11.

August 24, 2021
·
5 min read